Short Bowel Syndrome Epidemiology and Market Forecast Sheds Light on Growth Trends in the 7MM Until 2032 – ResearchAndMarkets.com

Short Bowel Syndrome Epidemiology and Market Forecast Sheds Light on Growth Trends in the 7MM Until 2032 – ResearchAndMarkets.com




Short Bowel Syndrome Epidemiology and Market Forecast Sheds Light on Growth Trends in the 7MM Until 2032 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Short Bowel Syndrome – Epidemiology Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering.


The healthcare industry has witnessed a significant addition to its library of market research with the publication of a comprehensive analysis and forecast on Short Bowel Syndrome (SBS) epidemiology in the 7MM, which includes insights into the patient population and forecasted market trends up to the year 2032. This research delves deep into the intricacies of SBS, a condition that presents substantial burdens to affected individuals and the healthcare system.

The report uncovers key elements such as the illness’s impact across different demographics and geographies. According to the research findings, in 2022, the total prevalent cases of home parenteral nutrition (HPN) in the 7MM approximated 40,000, with the United States reporting nearly 14,000 cases. These insights signify a concentrated effort to better understand and address the challenges encountered in the management of SBS.

In a detailed analysis, the report further outlines the state of SBS in the EU4 and the UK, with Germany reporting the highest number of cases, followed by the UK. Spain, on the other hand, recorded the lowest figures within this group. The research also extends into the Asia-Pacific region, highlighting Japan’s contribution to SBS epidemiology with its case count.

The valuable epidemiological insights address pivotal questions affecting the growth opportunities in the SBS patient population, historical and forecasted epidemiology, contributor demographics, and diagnostics-related challenges.

The investigation into Short Bowel Syndrome offers detailed segments, which include:

  • Prevalent cases of home parenteral nutrition (HPN)
  • Diagnosed prevalent cases of Short Bowel Syndrome
  • Age-specific and gender-specific cases of SBS
  • Etiology-specific cases of SBS

Other key insights from the Short Bowel Syndrome report include:

  • Diagnostic trends, practices, and emerging therapies in the SBS landscape
  • Patient population by gender, etiology, and age across multiple geographies
  • Current and forecasted market trends of Short Bowel Syndrome from 2019 to 2032

For more information about this report visit https://www.researchandmarkets.com/r/3tnant

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900